Tirzepatide Microdose
Tirzepatide Microdose, on prescription after an online consultation with a licensed doctor.
Plans
| Plan | Billed | Price |
|---|---|---|
| 1 mg · every month | Every 28 days, until cancelled | ₱4,490.00 VAT inclusive |
| 1 mg · every month · 3-month plan | Every 3 months, until cancelled | ₱12,390.00 VAT inclusive |
At a glance
- Reduces appetite and curbs cravings
- Once-weekly injection
- Low dose for a smooth and easy start
- How it is taken
- Injected under the skin, once a week
- Where to inject
- Stomach area
- Thigh
- Upper arm
- Storing it
- Keep it in the fridge at 2–8°C until you start using it. Do not freeze it — a pen or vial that has frozen must be thrown away. Keep away from light and out of reach of children. Once you have started a pen or vial, check its label for how long it may stay at room temperature, and do not use it beyond that. Do not use it if the liquid is cloudy, coloured or has particles in it.
Before you start
- Common side effects
- The most common side effects include nausea, diarrhea, vomiting, constipation, and abdominal discomfort. These are usually temporary and improve as your body adjusts to the medication. If these symptoms persist or worsen, consult your doctor.
- Stop and get help if
- Thyroid tumors: Symptoms may include a lump in the neck, trouble swallowing, or persistent hoarseness.
- Pancreatitis: Severe abdominal pain, with or without vomiting, may indicate inflammation of the pancreas.
- Severe hypoglycemia: Particularly if combined with insulin or sulfonylureas—symptoms include shakiness, confusion, dizziness, or excessive sweating.
- Kidney problems: Dehydration from persistent nausea, vomiting, or diarrhea can lead to kidney damage.
- Severe allergic reactions: Such as rash, itching, swelling, or difficulty breathing.
- Not for you if
- Have a personal or family history of medullary thyroid carcinoma (MTC).
- Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- Are allergic to tirzepatide or any of its ingredients.
- Pregnancy
- Ask your doctor first
- Breastfeeding
- Ask your doctor first
What it is
Compounded tirzepatide is a GLP-1 treatment made with the same active ingredient as Mounjaro®, compounded here in the Philippines by a licensed partner pharmacy, at a fraction of the branded price. Losing weight was never about willpower, it's biology. Tirzepatide activates two hormones your body already makes, GLP-1 and GIP, so your appetite quiets. And because it's compounded, your dose is personalized to you, guided by a licensed Filipino doctor.
How to take it
Inject your dose once a week, on the same day each week, under the skin of your stomach, thigh or upper arm. Use the syringes in your box and change the injection site each week. You start at 1 mg a week. Each month your doctor reviews how you are doing and may step your dose up, one step a month: 1 mg, 1.5 mg, 2 mg, 3 mg. 3 mg is the highest Microdose dose. If your doctor recommends more, they move you to compounded tirzepatide starter with your agreement. Only take the dose your doctor has prescribed. If you miss a dose, take it as soon as you can within 4 days; if more than 4 days have passed, skip it and take the next one on your usual day. Don't take two doses in one week.
The schedule
Once a week; dose stepped monthly 1→3 mg
What to expect
Some patients report reduced appetite and early weight loss within the first 2 to 4 weeks. More significant results typically appear by 8 to 12 weeks.
When to stop and seek help
Some people don't feel anything, others feel it briefly: nausea, diarrhea, constipation, or stomach discomfort. These are usually mild to moderate and tend to fade as your body adjusts, which is exactly why your dose goes up slowly instead of all at once. And you're never left to figure it out alone. If anything feels off, your &you doctor is a message away, consultations included. At Microdose doses, side effects are usually milder and less frequent, but they can still happen. Tell your doctor if they don't settle.
When it is not for you
Do not use Compounded Tirzepatide if you: - Have a personal or family history of medullary thyroid carcinoma (MTC). - Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). - Are allergic to tirzepatide or any of its ingredients. If you’re unsure about your medical history, consult your healthcare provider before starting this treatment.
The small print
A mandatory doctor consultation is required before starting treatment. During the consultation, you will receive training from our doctor and detailed usage information to ensure you can safely prepare your dose for self-administration. Our weight loss medications are intended for patients with a BMI ≥30 kg/m² or ≥27 with at least one weight-related comorbidity. Patients with type 1 diabetes are not eligible for treatment. You may use our BMI calculator to check your eligibility or consult our doctors to determine suitability for treatment. Please note that the vial is intentionally not full, but contains the exact amount personally prescribed by our doctors for each patient. Our tirzepatide is compounded by a licensed pharmacy. It is not FDA-approved and is prescribed case-by-case when appropriate; use only under clinician supervision.